Effect of Gut Microbiota and Its Metabolites on the Efficacy of Immunotherapy in Metastatic Colorectal Cancer

NCT06714903 · clinicaltrials.gov ↗

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Neoplasms Malignant

Interventions

OTHER: treatment option-sintilimab plus fruquintinib
OTHER: treatment option-fruquintinib alone

Sponsor

The First Hospital of Jilin University